Tech Company Financing Transactions
STAT-Diagnostica Funding Round
STAT-Diagnostica, based in Barcelona, scored funding from Boehringer Ingelheim Venture Fund, Caixa Capital and Gilde Healthcare Partners.
Transaction Overview
Company Name
Announced On
10/6/2016
Transaction Type
Venture Equity
Amount
Unknown
Round
Series C
Investors
Proceeds Purpose
The additional proceeds will be used to support the 2017 European launch of its DiagCORE Near Patient Testing system.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Baldiri Reixac 4
Barcelona, 08028
Spain
Barcelona, 08028
Spain
Phone
Website
Email Address
Overview
The DiagCORE platform is designed to meet the requirements of decentralized testing environments without compromising assay quality and performance. Our systems deliver true walk-away solutions in single-test consumables offering end-to-end sample to results with the shortest turnaround times.
Management Team
Browse more venture capital transactions:
Prev: 10/6/2016: MediaShift venture capital transaction
Next: 10/6/2016: Clearpath Robotics venture capital transaction
Share this article
Where The Data Comes From
We document every notable VC transaction. VC investment data records reported here come from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs